Advertisement
New Zealand markets closed

  • NZX 50

    11,557.21
    -121.47 (-1.04%)
     

  • NZD/USD

    0.6106
    -0.0011 (-0.18%)
     

  • ALL ORDS

    7,895.90
    -39.80 (-0.50%)
     

  • OIL

    79.13
    -0.10 (-0.13%)
     

  • GOLD

    2,358.20
    -5.90 (-0.25%)
     

OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2-min read

For the quarter ended March 2024, OPKO Health (OPK) reported revenue of $173.7 million, down 26.9% over the same period last year. EPS came in at -$0.12, compared to -$0.02 in the year-ago quarter.

The reported revenue represents a surprise of -5.00% over the Zacks Consensus Estimate of $182.84 million. With the consensus EPS estimate being -$0.09, the EPS surprise was -33.33%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how OPKO Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- Revenue from transfer of intellectual property and other: $8.70 million compared to the $13.37 million average estimate based on five analysts. The reported number represents a change of -86.6% year over year.

  • Revenues- Revenue from products: $38.10 million compared to the $40.66 million average estimate based on five analysts. The reported number represents a change of -5.7% year over year.

  • Revenues- Revenue from services: $126.90 million compared to the $126.93 million average estimate based on five analysts. The reported number represents a change of -4.2% year over year.

View all Key Company Metrics for OPKO Health here>>>

Shares of OPKO Health have returned -5.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

OPKO Health, Inc. (OPK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research